{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:55:04Z","timestamp":1783652104512,"version":"3.55.0"},"reference-count":58,"publisher":"American Society of Hematology","issue":"2","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,9]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Bone marrow failure (BMF) syndromes are heterogeneous diseases characterized by impaired hematopoiesis and a risk of evolution to myelodysplastic syndrome (MDS) and leukemia. We report 6 unrelated individuals with variable BMF phenotypes and hypocellular MDS, presenting at a median age of 10 years (range, 4 weeks to 53 years). Genomic analysis revealed germ line heterozygous variants in mouse double minute 4 (MDM4), including 4 null (frameshift, nonsense, and splice site resulting in premature truncation confirmed by RNA sequencing) and 2 missense variants, of which 1 had previously been associated with a familial BMF syndrome. Mechanistically, MDM4 mutations are loss-of-function mutations leading to enhanced p53 activation. We used CRISPR\/Cas9 to delete MDM4 in healthy donor hematopoietic stem and progenitor cells (HSPCs). The resulting MDM4-haploinsufficient HSPCs exhibited increased p53 activity, impaired colony-forming capacity, and reduced engraftment potential in immunodeficient mice. Complementation studies revealed both p53-binding and RING-finger domains as necessary for MDM4-mediated hematopoietic regulation. To study variant effects in a confounder-free genetic background, we introduced patient-specific MDM4 variants into induced pluripotent stem cells (iPSCs). MDM4-mutant iPSCs yielded significantly reduced erythroid and myeloid cells and exhibited increased p53 activity, as evidenced by elevated p21 expression, confirming the role of MDM4 in regulating hematopoiesis through p53. Transcriptome analysis of iPSC-derived hematopoietic cells revealed upregulation of the p53 pathway. Importantly, 1 patient with MDS acquired loss-of-function TP53 mutations, suggesting maladaptive somatic rescue. Our findings establish MDM4 deficiency as a TP53-activating syndrome, with features of BMF and variable hematopoietic manifestations. This study also highlights the critical role of the MDM4-p53 axis in maintaining hematopoietic homeostasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2024027180","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T19:55:33Z","timestamp":1772222133000},"page":"161-174","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["MDM4 haploinsufficiency leads to p53-mediated bone marrow failure"],"prefix":"10.1182","volume":"148","author":[{"given":"Richa","family":"Sharma","sequence":"first","affiliation":[{"name":"1Department of Hematology, St. Jude Children\u2019s Research Hospital, Memphis, TN"},{"name":"2Cleveland Clinic Research, Cleveland Clinic Foundation, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1402-6549","authenticated-orcid":false,"given":"Senthil Velan","family":"Bhoopalan","sequence":"additional","affiliation":[{"name":"3Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5693-2216","authenticated-orcid":false,"given":"Robert","family":"Meyer","sequence":"additional","affiliation":[{"name":"4Institute for Human Genetics and Genomic Medicine, Medical Faculty, Rheinisch-Westf\u00e4lische Technische Hochschule, Aachen University, Aachen, Germany"},{"name":"5Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Han","sequence":"additional","affiliation":[{"name":"1Department of Hematology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarna","family":"Beesetti","sequence":"additional","affiliation":[{"name":"1Department of Hematology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Liu","sequence":"additional","affiliation":[{"name":"3Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Singh","sequence":"additional","affiliation":[{"name":"3Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2519-8602","authenticated-orcid":false,"given":"Lance","family":"Palmer","sequence":"additional","affiliation":[{"name":"1Department of Hematology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baranda S.","family":"Hansen","sequence":"additional","affiliation":[{"name":"6Center for Advanced Genome Engineering, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1136-091X","authenticated-orcid":false,"given":"Majd","family":"Khiami","sequence":"additional","affiliation":[{"name":"1Department of Hematology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9461-0728","authenticated-orcid":false,"given":"Lise","family":"Larcher","sequence":"additional","affiliation":[{"name":"7Institut de Recherche Saint-Louis, Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"8INSERM U944\/Centre National de la Recherche Scientifique, Unit\u00e9 Mixte de Recherche 7212, Paris, France"},{"name":"9Saint-Louis Hospital, Hematology Laboratory, Assistance Publique H\u00f4pitaux de Paris, Paris, France"},{"name":"10Centre de R\u00e9f\u00e9rence Maladies Rares \u201cAplasie M\u00e9dullaire,\u201d Saint-Louis and Robert Debr\u00e9 Hospitals, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4659-8437","authenticated-orcid":false,"given":"Matthias","family":"Begemann","sequence":"additional","affiliation":[{"name":"4Institute for Human Genetics and Genomic Medicine, Medical Faculty, Rheinisch-Westf\u00e4lische Technische Hochschule, Aachen University, Aachen, Germany"},{"name":"5Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Corbacioglu","sequence":"additional","affiliation":[{"name":"11Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University Hospital of Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3709-4517","authenticated-orcid":false,"given":"Lara","family":"Heller","sequence":"additional","affiliation":[{"name":"12Zentrum f\u00fcr Humangenetik T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Jakob","sequence":"additional","affiliation":[{"name":"11Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University Hospital of Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5022-2053","authenticated-orcid":false,"given":"Yan","family":"Ju","sequence":"additional","affiliation":[{"name":"1Department of Hematology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushree S.","family":"Sahoo","sequence":"additional","affiliation":[{"name":"1Department of Hematology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Gray","sequence":"additional","affiliation":[{"name":"1Department of Hematology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Gheorghe","sequence":"additional","affiliation":[{"name":"13Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5088-1369","authenticated-orcid":false,"given":"Miriam","family":"Elbracht","sequence":"additional","affiliation":[{"name":"4Institute for Human Genetics and Genomic Medicine, Medical Faculty, Rheinisch-Westf\u00e4lische Technische Hochschule, Aachen University, Aachen, Germany"},{"name":"5Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Khurana","sequence":"additional","affiliation":[{"name":"14Klinik f\u00fcr Kinder- und Jugendmedizin, Evangelisches Klinikum Bethel, Bielefeld, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4556-6353","authenticated-orcid":false,"given":"Martin","family":"Kirschner","sequence":"additional","affiliation":[{"name":"5Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf, Germany"},{"name":"15Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, Rheinisch-Westf\u00e4lische Technische Hochschule, Aachen University, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5642-8378","authenticated-orcid":false,"given":"Ingo","family":"Kurth","sequence":"additional","affiliation":[{"name":"4Institute for Human Genetics and Genomic Medicine, Medical Faculty, Rheinisch-Westf\u00e4lische Technische Hochschule, Aachen University, Aachen, Germany"},{"name":"5Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7261-1447","authenticated-orcid":false,"given":"Miriam","family":"Erlacher","sequence":"additional","affiliation":[{"name":"16Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9677-3723","authenticated-orcid":false,"given":"Tim H.","family":"Br\u00fcmmendorf","sequence":"additional","affiliation":[{"name":"5Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf, Germany"},{"name":"15Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, Rheinisch-Westf\u00e4lische Technische Hochschule, Aachen University, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Soulier","sequence":"additional","affiliation":[{"name":"7Institut de Recherche Saint-Louis, Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"8INSERM U944\/Centre National de la Recherche Scientifique, Unit\u00e9 Mixte de Recherche 7212, Paris, France"},{"name":"9Saint-Louis Hospital, Hematology Laboratory, Assistance Publique H\u00f4pitaux de Paris, Paris, France"},{"name":"10Centre de R\u00e9f\u00e9rence Maladies Rares \u201cAplasie M\u00e9dullaire,\u201d Saint-Louis and Robert Debr\u00e9 Hospitals, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3793-585X","authenticated-orcid":false,"given":"Shondra M.","family":"Pruett-Miller","sequence":"additional","affiliation":[{"name":"6Center for Advanced Genome Engineering, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Beier","sequence":"additional","affiliation":[{"name":"5Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf, Germany"},{"name":"15Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, Rheinisch-Westf\u00e4lische Technische Hochschule, Aachen University, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6638-9643","authenticated-orcid":false,"given":"Marcin W.","family":"Wlodarski","sequence":"additional","affiliation":[{"name":"1Department of Hematology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2026070911211683900_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.seminhematol.2017.04.004","article-title":"Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia","volume":"54","author":"Savage","year":"2017","journal-title":"Semin Hematol"},{"issue":"1","key":"2026070911211683900_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.seminhematol.2018.05.016","article-title":"Acquired and germline predisposition to bone marrow failure: diagnostic features and clinical implications","volume":"56","author":"Kallen","year":"2019","journal-title":"Semin Hematol"},{"key":"2026070911211683900_bib3","doi-asserted-by":"crossref","first-page":"17032","DOI":"10.1038\/nrdp.2017.32","article-title":"Severe congenital neutropenias","volume":"3","author":"Skokowa","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2026070911211683900_bib4","doi-asserted-by":"crossref","first-page":"108476","DOI":"10.1016\/j.mrrev.2023.108476","article-title":"Congenital neutropenia: from lab bench to clinic bedside and back","volume":"793","author":"Dobrewa","year":"2024","journal-title":"Mutat Res Rev Mutat Res"},{"issue":"2","key":"2026070911211683900_bib5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41576-022-00527-z","article-title":"Genetics of human telomere biology disorders","volume":"24","author":"Revy","year":"2023","journal-title":"Nat Rev Genet"},{"issue":"3","key":"2026070911211683900_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrc.2017.116","article-title":"Fanconi anaemia and cancer: an intricate relationship","volume":"18","author":"Nalepa","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2026070911211683900_bib7","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41467-021-21588-4","article-title":"Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome","volume":"12","author":"Kennedy","year":"2021","journal-title":"Nat Commun"},{"key":"2026070911211683900_bib8","doi-asserted-by":"crossref","first-page":"570084","DOI":"10.3389\/fped.2020.570084","article-title":"DNA Repair Syndromes and cancer: insights into genetics and phenotype patterns","volume":"8","author":"Sharma","year":"2020","journal-title":"Front Pediatr"},{"issue":"5","key":"2026070911211683900_bib9","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S2352-3026(24)00063-2","article-title":"Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement","volume":"11","author":"Wlodarski","year":"2024","journal-title":"Lancet Haematol"},{"issue":"1","key":"2026070911211683900_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161810","article-title":"An RPS19-edited model for Diamond-Blackfan anemia reveals TP53-dependent impairment of hematopoietic stem cell activity","volume":"8","author":"Bhoopalan","year":"2023","journal-title":"JCI Insight"},{"issue":"1","key":"2026070911211683900_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.stem.2012.05.013","article-title":"Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53\/p21 DNA damage response that impairs hematopoietic stem and progenitor cells","volume":"11","author":"Ceccaldi","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"9","key":"2026070911211683900_bib12","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1182\/blood-2010-07-295238","article-title":"Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells","volume":"117","author":"Dutt","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2026070911211683900_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.stemcr.2017.06.015","article-title":"p53 mediates failure of human definitive hematopoiesis in dyskeratosis congenita","volume":"9","author":"Fok","year":"2017","journal-title":"Stem Cell Rep"},{"issue":"23","key":"2026070911211683900_bib14","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1182\/blood-2011-08-371963","article-title":"Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia","volume":"118","author":"Jaako","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2026070911211683900_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.stem.2016.08.021","article-title":"Mesenchymal inflammation drives genotoxic stress in hematopoietic stem cells and predicts disease evolution in human pre-leukemia","volume":"19","author":"Zambetti","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2026070911211683900_bib16","doi-asserted-by":"crossref","first-page":"e29558","DOI":"10.1002\/pbc.29558","article-title":"De novo TP53 germline activating mutations in two patients with the phenotype mimicking Diamond-Blackfan anemia","volume":"69","author":"Fedorova","year":"2022","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"2026070911211683900_bib17","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/ajmg.a.62749","article-title":"The germline p53 activation syndrome: a new patient further refines the clinical phenotype","volume":"188","author":"Kumar","year":"2022","journal-title":"Am J Med Genet A"},{"issue":"3","key":"2026070911211683900_bib18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajhg.2018.07.020","article-title":"De novo mutations activating germline TP53 in an inherited bone-marrow-failure syndrome","volume":"103","author":"Toki","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"12","key":"2026070911211683900_bib19","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S1470-2045(21)00580-5","article-title":"Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study","volume":"22","author":"de Andrade","year":"2021","journal-title":"Lancet Oncol"},{"issue":"11","key":"2026070911211683900_bib20","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041584","article-title":"New paradigms in the clinical management of Li-Fraumeni syndrome","volume":"14","author":"Giovino","year":"2024","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2026070911211683900_bib21","volume-title":"GeneReviews [Internet]","author":"Schneider","year":"1993"},{"issue":"15","key":"2026070911211683900_bib22","doi-asserted-by":"crossref","first-page":"eaay3511","DOI":"10.1126\/sciadv.aay3511","article-title":"Germline mutation of MDM4, a major p53 regulator, in a familial syndrome of defective telomere maintenance","volume":"6","author":"Toufektchan","year":"2020","journal-title":"Sci Adv"},{"issue":"3","key":"2026070911211683900_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/jmcb\/mjz007","article-title":"The long and the short of it: the MDM4 tail so far","volume":"11","author":"Haupt","year":"2019","journal-title":"J Mol Cell Biol"},{"issue":"15","key":"2026070911211683900_bib24","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1128\/MCB.22.15.5527-5538.2002","article-title":"Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development","volume":"22","author":"Migliorini","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2026070911211683900_bib25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ng714","article-title":"Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53","volume":"29","author":"Parant","year":"2001","journal-title":"Nat Genet"},{"issue":"1","key":"2026070911211683900_bib26","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1038\/s41598-019-40896-w","article-title":"CRIS.py: a versatile and high-throughput analysis program for CRISPR-based genome editing","volume":"9","author":"Connelly","year":"2019","journal-title":"Sci Rep"},{"key":"2026070911211683900_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-0716-2990-1_6","article-title":"High-throughput analysis of CRISPR-Cas9 editing outcomes in cell and animal models using CRIS.py","volume":"2631","author":"Narina","year":"2023","journal-title":"Methods Mol Biol"},{"issue":"5","key":"2026070911211683900_bib28","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41551-023-01026-0","article-title":"Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice","volume":"7","author":"Everette","year":"2023","journal-title":"Nat Biomed Eng"},{"issue":"10","key":"2026070911211683900_bib29","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41588-018-0204-y","article-title":"Mutational processes shape the landscape of TP53 mutations in human cancer","volume":"50","author":"Giacomelli","year":"2018","journal-title":"Nat Genet"},{"issue":"14","key":"2026070911211683900_bib30","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.1073\/pnas.1431692100","article-title":"Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis","volume":"100","author":"Kato","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2026070911211683900_bib31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/jmg.38.4.253","article-title":"Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome","volume":"38","author":"Bougeard","year":"2001","journal-title":"J Med Genet"},{"issue":"15","key":"2026070911211683900_bib32","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1182\/blood-2014-05-574111","article-title":"p53 mediates loss of hematopoietic stem cell function and lymphopenia in Mysm1 deficiency","volume":"125","author":"Belle","year":"2015","journal-title":"Blood"},{"issue":"17","key":"2026070911211683900_bib33","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.2024024607","article-title":"Germline ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition","volume":"144","author":"Zerella","year":"2024","journal-title":"Blood"},{"issue":"3","key":"2026070911211683900_bib34","doi-asserted-by":"crossref","first-page":"101197","DOI":"10.1016\/j.beha.2020.101197","article-title":"Germline predisposition in myeloid neoplasms: unique genetic and clinical features of GATA2 deficiency and SAMD9\/SAMD9L syndromes","volume":"33","author":"Sahoo","year":"2020","journal-title":"Best Pract Res Clin Haematol"},{"issue":"10","key":"2026070911211683900_bib35","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41591-021-01511-6","article-title":"Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9\/SAMD9L syndromes","volume":"27","author":"Sahoo","year":"2021","journal-title":"Nat Med"},{"issue":"5","key":"2026070911211683900_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10050135","article-title":"The guardian of the genome revisited: p53 downregulates genes required for telomere maintenance, DNA repair, and centromere structure","volume":"10","author":"Toufektchan","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2026070911211683900_bib37","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.celrep.2013.05.028","article-title":"Mutant mice lacking the p53 C-terminal domain model telomere syndromes","volume":"3","author":"Simeonova","year":"2013","journal-title":"Cell Rep"},{"key":"2026070911211683900_bib38","doi-asserted-by":"crossref","first-page":"11091","DOI":"10.1038\/ncomms11091","article-title":"p53 downregulates the Fanconi anaemia DNA repair pathway","volume":"7","author":"Jaber","year":"2016","journal-title":"Nat Commun"},{"issue":"4","key":"2026070911211683900_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41580-019-0110-x","article-title":"The multiple mechanisms that regulate p53 activity and cell fate","volume":"20","author":"Hafner","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"2026070911211683900_bib40","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","article-title":"Putting p53 in Context","volume":"170","author":"Kastenhuber","year":"2017","journal-title":"Cell"},{"issue":"11","key":"2026070911211683900_bib41","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41419-022-05408-1","article-title":"Mutant p53 in cancer: from molecular mechanism to therapeutic modulation","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis"},{"issue":"23","key":"2026070911211683900_bib42","first-page":"2853","article-title":"The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia","volume":"141","author":"Hakkarainen","year":"2023","journal-title":"Blood"},{"issue":"25","key":"2026070911211683900_bib43","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1182\/blood-2019-01-895698","article-title":"Familial predisposition to TP53\/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosum","volume":"133","author":"Sarasin","year":"2019","journal-title":"Blood"},{"issue":"23","key":"2026070911211683900_bib44","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1182\/blood.2024025023","article-title":"Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescuing and cancer mutations","volume":"144","author":"Gutierrez-Rodrigues","year":"2024","journal-title":"Blood"},{"issue":"2","key":"2026070911211683900_bib45","doi-asserted-by":"crossref","first-page":"e1125986","DOI":"10.1080\/23723556.2015.1125986","article-title":"Characterization of cancer-associated missense mutations in MDM2","volume":"3","author":"Chauhan","year":"2016","journal-title":"Mol Cell Oncol"},{"key":"2026070911211683900_bib46","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12935-019-0937-4","article-title":"The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumors","volume":"19","author":"Hou","year":"2019","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2026070911211683900_bib47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1158\/1078-0432.CCR-12-0053","article-title":"Molecular pathways: targeting Mdm2 and Mdm4 in cancer therapy","volume":"19","author":"Li","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2026070911211683900_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40001-024-01684-z","article-title":"MDM4 was associated with poor prognosis and tumor-immune infiltration of cancers","volume":"29","author":"Liu","year":"2024","journal-title":"Eur J Med Res"},{"issue":"2","key":"2026070911211683900_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2023.01.006","article-title":"Clonal hematopoiesis driven by chromosome 1q\/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia","volume":"30","author":"Sebert","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2026070911211683900_bib50","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jmcb\/mjy070","article-title":"Tumor suppressor p53 and metabolism","volume":"11","author":"Liu","year":"2019","journal-title":"J Mol Cell Biol"},{"issue":"1","key":"2026070911211683900_bib51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood-2008-10-180489","article-title":"GATA-1 associates with and inhibits p53","volume":"114","author":"Trainor","year":"2009","journal-title":"Blood"},{"issue":"8","key":"2026070911211683900_bib52","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/sj.cdd.4401962","article-title":"The p53-Bcl-2 connection","volume":"13","author":"Hemann","year":"2006","journal-title":"Cell Death Differ"},{"issue":"14","key":"2026070911211683900_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2021.06.013","article-title":"A p53-dependent translational program directs tissue-selective phenotypes in a model of ribosomopathies","volume":"56","author":"Tiu","year":"2021","journal-title":"Dev Cell"},{"issue":"3","key":"2026070911211683900_bib54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cell.2008.06.028","article-title":"p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling","volume":"134","author":"Budanov","year":"2008","journal-title":"Cell"},{"issue":"2","key":"2026070911211683900_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2019.01.006","article-title":"p53 is a master regulator of proteostasis in SMARCB1-deficient malignant rhabdoid tumors","volume":"35","author":"Carugo","year":"2019","journal-title":"Cancer Cell"},{"issue":"436","key":"2026070911211683900_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao3003","article-title":"Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia","volume":"10","author":"Carvajal","year":"2018","journal-title":"Sci Transl Med"},{"issue":"19","key":"2026070911211683900_bib57","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1158\/1078-0432.CCR-21-0715","article-title":"Phase 1 trial of ALRN-6924, a dual inhibitor of MDMX and MDM2, in patients with solid tumors and lymphomas bearing wild-type TP53","volume":"27","author":"Saleh","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2026070911211683900_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020266","article-title":"Targeting the RNA polymerase I transcription for cancer therapy comes of age","volume":"9","author":"Ferreira","year":"2020","journal-title":"Cells"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/2\/161\/2531990\/blood_bld-2024-027180-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/2\/161\/2531990\/blood_bld-2024-027180-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:21:28Z","timestamp":1783610488000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/2\/161\/566882\/MDM4-haploinsufficiency-leads-to-p53-mediated-bone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,7,9]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024027180","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,9]]},"published":{"date-parts":[[2026,7,9]]}}}